🇺🇸 Insulin Lispro-aabc in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain Upper — 2 reports (16.67%)
  2. Injection Site Pain — 2 reports (16.67%)
  3. Abdominal Abscess — 1 report (8.33%)
  4. Abdominal Discomfort — 1 report (8.33%)
  5. Abdominal Hernia — 1 report (8.33%)
  6. Acute Cholecystitis Necrotic — 1 report (8.33%)
  7. Arthritis — 1 report (8.33%)
  8. Arthropathy — 1 report (8.33%)
  9. Blood Glucose Increased — 1 report (8.33%)
  10. Death — 1 report (8.33%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Insulin Lispro-aabc approved in United States?

Insulin Lispro-aabc does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Insulin Lispro-aabc in United States?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.